You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Correction: Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

https://doi.org/10.1136/jitc-2022-005828corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Franklin C, Mohr P, Bluhm L, et al. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 2023;11:e005828. doi: 10.1136/jitc-2022-005828

    In this article, the authorship has been updated. Karin Scharffetter-Kochanek has been replaced by Anca Sindrilaru.